In today’s recent session, 0.65 million shares of the Compugen Ltd (NASDAQ:CGEN) have been traded, and its beta is 2.63. Most recently the company’s share price was $2.31, and it changed around $0.06 or 2.67% from the last close, which brings the market valuation of the company to $206.83M. CGEN at last check was trading at a discount to its 52-week high of $3.03, offering almost -31.17% off that amount. The share price’s 52-week low was $1.35, which indicates that the recent value has risen by an impressive 41.56% since then. We note from Compugen Ltd’s average daily trading volume that its 10-day average is 1.37 million shares, with the 3-month average coming to 531.27K.
Compugen Ltd stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended CGEN as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Compugen Ltd is expected to report earnings per share of -0.08 for the current quarter.
Compugen Ltd (NASDAQ:CGEN) trade information
Instantly CGEN has been showing a green trend so far today with a performance of 2.67% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.45 on recent trading dayincreased the stock’s daily price by 5.71%. The company’s shares are currently up 50.98% year-to-date, but still up 16.08% over the last five days. On the other hand, Compugen Ltd (NASDAQ:CGEN) is 45.28% up in the 30-day period. We can see from the shorts that 1.27 million shares have been sold at a short interest cover period of 6.42 day(s).
The consensus price target as assigned by Wall Street analysts is $4, which translates to bulls needing to increase their stock price by 42.25% from its current value. Analyst projections state that CGEN is forecast to be at a low of $4 and a high of $4.
Compugen Ltd (CGEN) estimates and forecasts
Compugen Ltd share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 26.92 percent over the past six months and at a 85.71% annual growth rate that is well above the industry average of 16.50%. The year-over-year growth rate is expected to be 31.12%, up from the previous year.
Consensus estimates provided by 3 financial analysts predict the company will bring in an average of 17.47M in revenue for the current quarter. 1 analysts expect Compugen Ltd to make 5M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 33.46M and 2.56M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -47.78%. Forecasts for the next quarter put sales growth at 95.39%. Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 12.14%.
Compugen Ltd (NASDAQ:CGEN)’s Major holders
TAYLOR FRIGON CAPITAL MANAGEMENT LLC, with 1.4685% or 1.31 million shares worth $2.21 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Delaware Group Equity Fds IV-Delaware Healthcare Fund and PFS Funds-Taylor Frigon Core Growth Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 1.02 shares worth $2.28 million, making up 1.14% of all outstanding shares. On the other hand, PFS Funds-Taylor Frigon Core Growth Fund held roughly 242.97 shares worth around $0.54 million, which represents about 0.27% of the total shares outstanding.
